Reactions Weekly

November 2019, Volume 1780, Issue 1, pp 154–154 | Cite as

Erenumab/fremanezumab/galcanezumab

Raynaud's phenomenon and exacerbation of Raynaud's phenomenon: 3 case reports

Case report

First Online: 23 November 2019

• 89 Downloads

This is a preview of subscription content, log in to check access.

Reference

1. Evans RW. Raynaud's Phenomenon Associated With Calcitonin Gene-Related Peptide Monoclonal Antibody Antagonists. Headache 59: 1360-1364, No. 8, Sep 2019. Available from: URL: http://doi.org/10.1111/head.13596 - USACrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019